Medicinal Chemistry

Ke Ding

Biography

Dr. Ding obtained his Ph.D. in Fudan University and Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences in 2001 after graduating from the China Pharmaceutical University. He received his post-doctoral training in University of Michigan during 2001-2004, and then worked as a Research Investigator. In 2006, Dr. Ding joined Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences as a Senior Principal Investigator, Doctoral Supervisor and Deputy Director of Chemical Biology Institute.

Research Interest

Prostate Cancer; Metastasis; Niclosamide; STAT3; MAPK, Prostate cancer is one of the most common cancer types among males. Metastasis in advanced stages of prostate cancer makes the disease refractory to current treatments and is the leading cause of death of advanced prostate cancer. Drugs targeting metastasis may provide new therapeutic strategies for advanced prostate cancer.

Relevant Topics